Feedback / Questions
tazarotene oral (GRI-0621) - GRI Bio
https://www.globenewswire.com/news-release/2025/06/26/3105778/0/en/GRI-Bio-s-GRI-0621-Demonstrates-Encouraging-Safety-Results-at-Planned-Interim-6-Week-Analysis-in-Ongoing-Phase-2a-Study-in-Idiopathic-Pulmonary-Fibrosis-IPF.html
Jun 26, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next